Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells

British Journal of Cancer

Volumn 84, Issue 11, 2001, Pages 1571-1576

  Nehme A ^a   Varadarajan, P ^a   Sellakumar, G ^a   Gerhold, M ^a   Niedner, H ^a   Zhang, Q ^a   Lin, X ^a   Christen, R D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

All trans retinoic acid; Apoptosis; Cell cycle; Docetaxel; Prostate cancer

Indexed keywords

DOCETAXEL; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DEATH; CELL GROWTH; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PHASE SEPARATION; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DOWN REGULATION; TRANSACTIVATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CYCLIN D1; DOWN-REGULATION; DRUG INTERACTIONS; HUMANS; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; TAXOIDS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0035365162     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1818     Document Type: Article

References (39)

1. All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squarmous head and neck cancer cells
2. Retinoid-sensitive cells and cell lines
3. Expression of Bcl-2-related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid
4. Activation of the p42 mitogen-activated protein kinase pathway inhibits cdc2 activation and entry into M-phase in cycling Xenopus egg extracts
5. Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression
6. Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: Relationship with induction of differentiation and retinoic acid receptor expression
7. Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian caminoma cell lines
8. Management of cancer of the prostate
9. Multiple drug-effect analysis
10. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
11. Mathematical analysis of DNA distributions derived from flow microfluorometry
12. Association of mitogen-activated protein kinases with microtubules in mouse macrophages
13. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity
14. Down-regulation of bcl-2 by p53 in breast cancer cells
15. Inactivation of Bcl-2 by phosphorylation
16. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells
17. Bcl2 is the guardian of microtubule integrity
18. Serme-70 is one of the critical sites for drug-induced Bcl-2 phosphorylation in cancer cells
19. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells
20. Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid
21. Specific proteolytic cleavage of poly(ADP-ribose)polymerase: An early marker of chemotherapy-induced apoptosis
22. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2
23. Suppression of squamous cell carcinoma growth and differentiation by retinoids
24. The retinoid receptors
25. The end of the cell line: Methods for the study of apoptosis
26. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
27. Retinoid-regulated expression of bcl-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells
28. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
29. Phase I trial of docetaxel estramustine in androgen-independent prostate cancer
30. Docetaxel as monotherapy in the treatment of hormone-reractory prostate cancer: Preliminary results
31. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts
32. Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid; a rationale for combination therapy with chemotherapeutic agents
33. A phase 11 study of docetaxel, estramustine and low dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B Trial 9780
34. Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukemia
35. Anticancer drug targets: Cell cycle and checkpoint control
36. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
37. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma
38. New colorimetric cytotoxicity assay for anticancer-drug screnning
39. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both ras and apoptosis signal-regulating kinase pathways